Skip to main content
. Author manuscript; available in PMC: 2017 Apr 18.
Published in final edited form as: Clin Gastroenterol Hepatol. 2015 Sep 25;14(5):753–759. doi: 10.1016/j.cgh.2015.08.041

Figure 2. Differences in Outcome by Intervention Phase.

Figure 2

A: The association of each phase with 30-day readmissions is depicted overall and for patients with hepatic encephalopathy (HE). * denotes a p value < 0.05.

B: The reasons for a 30-day readmission are described by intervention phase.